InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（7 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Rangwala Reshma, Vice-Présidente Exécutive et Directrice Médicale. Insider active across 1 company, notably Karyopharm Therapeutics Inc.. Aggregated, 15 filings have been published. Split: 0 buy · 7 sells. Total volume traded: €93k. History available since 29 April 2022. The latest transaction was disclosed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rangwala Reshma
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
947 股0Common StockSEC:0001193125-26-226685:0
449 股@ US$8.940.0088% mcap6.6% 占其流量Common StockSEC:0001825322-26-000006:0
5,066 股@ US$9.409543.8% 占其流量Common StockSEC:0001825322-26-000003:0
32,415 股0Common StockSEC:0001193125-26-035682:0
945 股0Common StockSEC:0001193125-25-205044:0
419 股@ US$6.174.7% 占其流量Common StockSEC:0000950170-25-058137:0
3,587 股@ US$6.2944.3% 占其流量Common StockSEC:0000950170-25-034732:0
5,416 股0Common StockSEC:0000950170-25-032315:0
6,789 股@ US$1.1715.3% 占其流量Common StockSEC:0000950170-24-046871:0
15,667 股@ US$1.1734.8% 占其流量CommonSEC:0000950170-24-025193:0
198,959 股0Common StockSEC:0000950170-24-023297:0
14,167 股0Common StockSEC:0000950170-24-007614:0
115 股@ US$4.02670.9% 占其流量Common StockSEC:0001209191-23-025464:0
100,000 股0Common StockSEC:0001209191-23-014873:0
65,000 股0Common StockSEC:0001209191-22-026425:0
15 条申报中的 15 条
About Rangwala Reshma
Rangwala Reshma is Executive Vice President and Chief Medical Officer, and is associated with Karyopharm Therapeutics Inc. (XNAS) as EVP & Chief Medical Officer. Across 15 filings in total, the 15 sampled filings run from 2022-05-02 to 2026-05-15, with 0 in purchases and 92544 in sales, and the stated transaction nature is Attribution.
